Can I read The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan on EtoBox?

The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan by Wang, Cheng-Yi (author);Lai, Chih-Cheng (author);Wang, Ya-Hui (author);Wang, Hao-Chien (author) is a Medicine article available to read on EtoBox.

What is The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan about?

This study aims to investigate the prevalence of short-acting β2-agonist (SABA) overuse in asthma and the associated risk of acute exacerbation and mortality in Taiwan. We used the Taiwanese pay-for-performance asthma program database, which included patients aged between 12 and 100 years who were enrolled in the program between 2001 and 2015. Among a total of 218,039 patients, 34,641 (15.9%) patients are classified as SABA over-users. Compared with patients who did not receive inhaled corticosteroids (ICS) and collected ≤2 canisters, SABA over-users had a higher risk of severe exacerbations. SABA over-users had a higher risk of all-cause mortality compared with patients who did not receive ICS and collected ≤2 canisters. The overall prevalence of SABA overuse in Taiwan is 15.9%, and this is even higher in concomitant ICS users. In addition, the overuse of SABA is associated with an increased risk of severe exacerbation and death.

Who reads The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan?

Author

Wang, Cheng-Yi (author);Lai, Chih-Cheng (author);Wang, Ya-Hui (author);Wang, Hao-Chien (author)

Publisher

Springer Science and Business Media LLC

Published

2021

Language

EN

Field

Medicine (Health Sciences)